Bio Base Europe Pilot Plant:

Transcription

1 Bio Base Europe Pilot Plant: Belang van open access piloot infrastructuur voor de uitrol van industriële biotechnologie en de bioeconomie Brecht Vanlerberghe, Head R&D BBEPP EWI-focus 24 Biogebaseerde industrie in Vlaanderen Brussel 22 maart 2017

2 Our playground: Bioeconomy to adressing societal challenges from fossil to renewable resources: GHG reduction, re-industrialisation, jobs, local resources Waste «Black» CO 2 Use Products Chemicals Energy Fossile resources

3 Our playground: KET IB & Bio economy Biotechnology is the use of biological processes, organisms, or systems to manufacture products intended to improve the quality of human life The colours of Biotechnology: Red Biotechnology medical biotechnology: e.g. vaccines, insuline Green Biotechnology plant biotechnology : e.g. plant resistant to insects, diseases White Biotechnology Industrial Biotechnology e.g. enzyme washing powders

4 Our playground: KET IB & Bio economy White Biotechnology : The use of microorganisms and their enzymes to produce chemical substances, materials and bio-energy from renewable resources Performant, robust & cost efficient biocatalysts: - Non food part Biomass is more recalcitrant - Hydrolysates are a soup

5 Deployment IB & Bio economy: What s missing? Research: turning money into knowledge mainly (bio)catalyst development (IP) typically lab enviroment Scientists Innovation: turning knowledge into money Techno economical feasibility, LCA? Market validation & value chains >> Prototypes Requires: Process & down stream process development thus >> larger infrastructure/ hardware >> expertise, skills / software or people >> Money & time

6 Deployment IB & Bio economy: What s missing? IB & Bio Economy: Risky: uncertain political climate (CO2 taxes, incentives, penalties,. ) see eg biofuels Low risk premium & longer payback time : profit margins lower than in e.g. pharma or red biotech >> difficult to convince management and/ or private investors Shared Pilot Facilities = risk sharing/reduction

7 Bio Base Europe Pilot Plant: o Multi-purpose pilot facility in the Port of Ghent (B) o Bio-Based products & processes o Current number of employees: 50 o Independent non-for-profit SME Investment in infrastructure (ERDF) o Interreg VL-NL : 13 m o Interreg NWE : 1,35m o ERDF : 1,26m o Interreg VL-NL BioHarT: 0,2mio From lab to industrial environment: o Process development & optimisation: proof op concept, opex, capex, LCA o Upscaling mg to g, kg, ton scale: prototypes for product & market validation o First series production: Market development

8 Process Hall 1 Biomass pretreatment, biocatalysis and DSP

9 Process Hall 2 Fermentations and DSP

10 Process Hall 3 Green chemistry and ATEX proof DSP

11 Laboratory Analysis and process development

12 Storage Storage of different kind of biomass

13 Our unique offer: A flexible and diverse pilot plant that covers the whole proces, from green resource to final product, under one roof

14 What we do! PRIVATELY FUNDED PROJECTS o With companies (start-ups, SME s & Large companies o IP owned by & remaining with companies PUBLICLY FUNDED PROJECTS: Technology development, scale up and Creating awareness & building new value chains o (financial) stability midlongterm o building expertise o communication/ publicity o developping IP, creates FTO

15 What we do! PRIVATELY FUNDED PROJECTS o Process development & optimisation: proof op concept, opex, capex, LCA o Upscaling mg to g, kg, ton scale product validation, market validation o First series production Market development projects/year Rest of the world: Canada, Hong Kong, Japan, US,

16 CURRENT: PUBLICLY FUNDED PROJECTS: Technology development, scale up and Creating awareness & building new value chains FP7 : NANO3BIO (chitosan) H2020: 2GBIOPIC (2G ethanol) Marisurf (marine biosurfactants) ERIFORE (circular economy forestry based) REHAP (valuable compounds from forestry residus) Superbio (support actions for biobased value chains) NanoPack, DAFIA, FALCON: H2020 BBI-joint undertaking: Pulp2value (Demo) (valorisation coproducts) Carbosurf (R&IA) (speciality carbohydrates & biosurfactants) DEMETER (demo) (enzymes for anaerobic digestion) Pilots4U, RESOLVE, AFTERLIFE: GA negotiation INTERREG NWE: Bio Base 4 SME (Support actions to SMEs) INTERREG EU: SmartPilots (network shared pilot facilities for Bio Economy) INTERREG Vl-NDL: BioHart (renewable aromatic molecules) UNDER EVALUATION: H2020-LCE-08 (1), H2020-SFS-35 (1); H2020-SFS-17(1); H2020-SC (1) Under construction: H2020-Biotec : (2 nd stage) 3 projects H2020-biotec : (2 nd Stage) 1 project H2020- INFRAIA (2 nd stage): 1 project H2020-INNOSUP : KETS4SME FISCH-ICON (FL) Enzymase: biocatalysis in chemical industry

17 Consortia projects Geographical distribution of European project partners within consortia based projects

18 Upscaling & validation Micro-organisms activities Bio Base Europe Pilot Plant Performance check co fermenting yeast at high solids SSF (20-30% DS) ( Enzymatic hydrolysis at high DS: inhibition C5?) De-ashed waste paper, SAA-fractionated cornstover & myscanthus GlobalYeast is a Belgian-Brazilian biotechnology startup focused on developing and deploying products and solutions for the fermentation industry.

19 PULP2VALUE Processing Underutilised Low value sugar beet Pulp into VALUE added products Scope of the project PULP2VALUE aims to extract between 20 and 50 times more value from sugar beet pulp (approx. 13 million tonnes annually in Europe). To obtain this, multiple extraction techniques were developed to isolate more valuable products from the pulp. Activities of Bio Base Europe Pilot Plant Identification, optimization and Integration unit operations Production prototypes for application development & market testing

20 We support SMEs and start-ups in the biobased sector training & networking We offer financial support towards services that can help the company to bring their innovation to market: 100 K max, % funded Network of expert organisation: terms of reference

21 SmartPilots aims to improve regional policies to provide support in a cost-effective and impact oriented manner. This will be done by: Optimizing direct support for shared pilot facilities Optimizing indirect support i.e. direct support for users of shared pilot facilities Facilitating interregional cooperation regarding Shared Pilot Facilities.

22 Experience & recommendation - From research to innovation, but. innovation trajectory not linear, iterations required - Open acces multipurpose pilot/demo facilities to reduce: - technological/financial risk - time to market - Critical mass (Staff & equipment) key factor for success, avoid scattering of resources - To save money: Fail Fast value chain approach with pilot/demo activities, - appropriate funding rates for innovation actions

23 More information? Brecht Vanlerberghe